medigraphic.com
ISSN 2448-8909 (Print)

2023, Number 3

<< Back Next >>

Med Crit 2023; 37 (3)

Pulmonary embolism disease due Leiden factor V mutation and antithrombin III deficiency

Giraldo JM, Uribe E, Giraldo JM, Duque C, Giraldo JV

Language: Spanish
References: 37
Page: 257-261
PDF size: 318.12 Kb.


ABSTRACT

We present a clinical case of a young male in the second decade of life who presented septic shock due to enterobacteria with extended resistance isolated in rectal swab requiring early sepsis campaign guidelines. Had severe pulmonary injury and markers of fibrinolytic activity, pulmonary perfusion is performed by nuclear medicine documenting pulmonary thromboembolism secondary to antithrombin III deficiency and Leiden factor V. It evolves favorably with recovery of ventilatory mechanics tolerating release of mechanical ventilation without compromise of oxygenation or ventilation so it is decided to transfer to internal medicine and hematology.


REFERENCES

  1. Barash GP, Cullen FB, Stoelting KR, Cahalan KM, Stock MC. Airway management. Clinical anesthesia. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 2009. pp. 751-777.

  2. Finucane BT, Tsui BCH, Santora AH. Chapter 9: The difficult airway. In: Finucane BT, Tsui BCH, Santora AH. Principle of airway management. 4th ed. New York: Ed. Springer; 2011. pp. 361-414.

  3. Dueñas C, Ortiz G, González M, Mejía J. Ventilación mecánica aplicada al paciente crítico. Ventilación en paciente neurológico. Colombia: Distribuna; 2011. pp. 325-339.

  4. Pelosi P, Ball L. Should we titrate ventilation based on driving pressure? Maybe not in the way we would expect. Ann Transl Med. 2018;6(19):389. doi: 10.21037/atm.2018.09.48.

  5. Vincent JL. Chapter 19. Veno arterial PCO2 gradient. In: The sepsis text. Massachusetts: Ed. Kluwer Academic Publishers; 2002. pp. 339-352.

  6. Teboul JL, Monnet X. Clinical use of venoarterial PCO2 difference in septic shock. In: Vincent JL. (eds) Intensive care medicine. New York, NY: Springer; 2003. pp. 574-582.

  7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858-73. doi: 10.1097/01.ccm.0000117317.18092.e4.

  8. Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2012;54(4):470-478.

  9. Giraldo JM, Beltrán E, Barranco E, Rojas L. Cardiac injury in a patient with pulmonary sepsis due to extended-spectrum beta-lactamase-producing E. coli. ACCI. 2016;16(4):294-299.

  10. Alhamdi Y, Abrams ST, Cheng Z, Jing S, Su D, Liu Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit Care Med. 2015;43(10):2094-2103.

  11. Giraldo JM, Beltrán E. Carboxihemoglobina como marcador de la actividad antiinflamatoria en leptospirosis grave; respecto a un reporte de caso. Acta Colomb Cuid Intensivo. 2020;20:61-65. doi: 10.1016/j.acci.2019.12.003.

  12. Coppola S, Froio S, Chiumello D. Higher vs. lower PEEP in ARDS: just one part of the whole. J Thorac Dis. 2018;10(1):56-59. doi: 10.21037/jtd.2017.12.46.

  13. Rezoagli E, Bellani G. How I set up positive end-expiratory pressure: evidence- and physiology-based. Crit Care. 2019;23(1):412. doi: 10.1186/s13054-019-2695-Z.

  14. Hess DR. Recruitment maneuvers and PEEP titration. Respir Care. 2015;60(11):1688-1704. doi: 10.4187/respcare.04409.

  15. Hassan A, Usman J, Kaleem F, Gill MM, Khalid A, Iqbal M, et al. Evaluation of different phenotypic methods for detection of amp C Beta-lactamase producing bacteria in clinical isolates. J Coll Physicians Surg Pak. 2013;23(9):629-632.

  16. Watanabe N, Fettich J, Kücük NO, Kraft O, Mut F, Choudhury P, et al. Modified PISAPED criteria in combination with ventilation scintigraphic finding for predicting acute pulmonary embolism. World J Nucl Med. 2015;14(3):178-183. doi: 10.4103/1450-1147.163248.

  17. Esteban A, Frutos F, Tobin MJ, Alía I, Solsona JF, Valverdú I, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med. 1995;332(6):345-350.

  18. Giraldo Sánchez JM, Badillo E, Pacheco J, Beltrán E, Barranco E. Liberación de la ventilación mecánica con sistema de asa cerrada en asistencia proporcional en paciente con síndrome de dificultad respiratoria del adulto de origen extrapulmonar. Acta Colomb Cuid Intensivo. 2015;15:132-142.

  19. Griffin JH, Evartt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin. 1981;68(5): 1370-1373.

  20. Bertina RM. Hereditary protein S deficiency. Haemostasis. 1985; 15(4)241-246.

  21. Leal AA, Palmeira AC, Castro GM, Simoes MO, Ramos AT, Medeiros CC. Homocysteine: cardiovascular risk factor in children and adolescents? Rev Assoc Med Bras. 2013;59(6):622-628. doi: 10.1016/j.ramb.2013.05.004.

  22. Senst B, Tadi P, Basit H, Jan A. Hypercoagulability. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

  23. Bravo-Pérez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol. 2019;12(6):397-405. doi: 10.1080/17474086.2019.1611424.

  24. Leal-Tijerina G, Alvarado-Barrientos M, Sosa-Gillaumin A. Hereditary antithrombin III deficiency. Report of an obstetric case and review of the literature. Ginecol Obstet Mex. 1996;64:177-183.

  25. Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018;169:23-29. doi: 10.1016/j.thromres.2018.07.008.

  26. Ehrhardt JD Jr, Boneva D, McKenney M, Elkbuli A. Antithrombin deficiency in trauma and surgical critical care. J Surg Res. 2020;256:536-542. doi: 10.1016/j.jss.2020.07.010.

  27. Kovac M. Antithrombin deficiency in pregnancy-the unresolved issues. Lancet Haematol. 2020;7(4):e276-e278. doi: 10.1016/S2352-3026(20)30038-7.

  28. Candito M, Candito E, Chatel M, van Obberghen E, Dunac A. Homocysteinemia and thrombophilic factors in unexplained decompression sickness. Rev Neurol (Paris). 2006;162(8-9):840-844. doi: 10.1016/s0035-3787(06)75087-1.

  29. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90(3):1004-1008.

  30. Varga E. Inherited thrombophilia: key points for genetic counseling. J Genet Couns. 2007;16(3):261-277. doi: 10.1007/s10897-006-9069-9.

  31. Khan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006;4:15.

  32. van Langevelde K, Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood. 2012;120(5):933-946.

  33. Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016;91(1):46-49.

  34. Kujovich JL. Factor V Leiden thrombophilia. Genet Med [internet]. 2011;13(1):1-16. Available in: http://www.ncbi.nlm.nih.gov/pubmed/21116184n

  35. Torres JD, Cardona H, Álvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, et al. Inherited thrombophilia is associa-ted with deep vein thrombosis in a Colombian population. Am J Hematol. 2006;81(12):933-937.

  36. Buitrago LE, Casas CP, Solano MH. Trombosis inusuales y trombofilia Un problema difícil de abordar. Experiencia de cuatro años. Acta Med Colomb. 2013;38(3):132-137.

  37. Lacayo-Leñero D, Hernández-Hernández D, Valencia-Martínez A, Barrales-Benítez O, Vargas-Ruiz AG. Primary thrombophilia in Mexico: a single tertiary referral hospital experience. Blood Coagul Fibrinolysis. 2016;27(8):920-924.




2020     |     www.medigraphic.com